Charles Schwab Investment Management Inc Ocular Therapeutix, Inc Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,110,460 shares of OCUL stock, worth $9.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,110,460
Previous 450,380
146.56%
Holding current value
$9.37 Million
Previous $3.08 Million
213.67%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding OCUL
# of Institutions
171Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$122 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$108 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$107 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$97.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$70.8 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $650M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...